Article Information
History
- May 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sebastian Havervall, MD1,#,
- Ulrika Marking, MD1,#,
- Nina Greilert-Norin, RN1,
- Henry Ng, MMSc1,2,
- Ann-Christin Salomonsson, BSc1,
- Cecilia Hellström3, MSc,
- Elisa Pin, PhD3,
- Kim Blom, PhD4,
- Sara Mangsbo, PhD5,
- Mia Phillipson, PhD2,
- Jonas Klingström, PhD4,6,
- Mikael Åberg, PhD7,
- Sophia Hober, PhD3,
- Peter Nilsson, PhD3 and
- Charlotte Thålin, PhD1,*
- 1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
- 2Department of Medical Cell Biology and Science for Life Laboratory Uppsala University, Uppsala, Sweden
- 3Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden
- 4Public Health Agency of Sweden, Solna, Sweden
- 5Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden
- 6Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
- 7Department of Medical Sciences, Clinical Chemistry and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- ↵*Corresponding author: Charlotte Thålin, M.D., Ph.D., Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 18288 Stockholm, Sweden, Phone: 08-12355000, E-mail: charlotte.thalin{at}sll.se
↵# these authors contributed equally
Posted May 11, 2021.
Antibody Responses After a Single Dose of ChAdOx1 nCoV-19 Vaccine in Healthcare Workers Previously Infected with SARS-CoV-2
